Evidence map›Paper›PMID 33105908›Full record

ArticleInternational journal of molecular sciences2020

Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging.

Kyung Oh Jung, Young-Hwa Kim, Seock-Jin Chung, Chul-Hee Lee, Siyeon Rhee, Guillem Pratx, June-Key Chung, Hyewon Youn

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Biodistribution studies ofApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kyung Oh JungDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Young-Hwa KimDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.ORCID 0000-0002-3064-5606
Seock-Jin ChungDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Chul-Hee LeeDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Siyeon RheeDepartment of Biology, Stanford University, Stanford, CA 94305, USA.
Guillem PratxDepartment of Radiation Oncology, Division of Medical Physics, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.
June-Key ChungDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Hyewon YounDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Seoul National University · KRStanford University · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
National Research Foundation (NRF) from Ministry of Science and ICT, Republic of Korea 2011-0030001National Research Foundation (NRF) from Ministry of Science and ICT, Republic of Korea 2017R1A2B4012813National Research Foundation (NRF) from Ministry of Science and ICT, Republic of Korea 2019R1I1A1A01057845National Research Foundation (NRF) from Ministry of Science and ICT, Republic of Korea 2020R1A2C2011695
6 · The paper itself

Abstract

There has been considerable interest in the clinical use of exosomes as delivery vehicles for treatments as well as for promising diagnostic biomarkers, but the physiological distribution of exosomes must be further elucidated to validate their efficacy and safety. Here, we aimed to develop novel methods to monitor exosome biodistribution in vivo using positron emission tomography (PET) and optical imaging. Exosomes were isolated from cultured mouse breast cancer cells and labeled for PET and optical imaging. In mice, radiolabeled and fluorescently labeled exosomes were injected both via lymphatic and hematogenous metastatic routes. PET and fluorescence images were obtained and quantified. Radioactivity and fluorescence intensity of ex vivo organs were measured. PET signals from exosomes in the lymphatic metastatic route were observed in the draining sentinel lymph nodes. Immunohistochemistry revealed greater exosome uptake in brachial and axillary versus inguinal lymph nodes. Following administration through the hematogenous metastasis pathway, accumulation of exosomes was clearly observed in the lungs, liver, and spleen. Exosomes from tumor cells were successfully labeled with

Indexed as

ExosomesAnimalsCarbocyaninesCopper RadioisotopesDrug Administration RoutesFemaleFluorescent DyesGallium RadioisotopesHeterocyclic Compounds, 1-RingInjections, IntravenousIsotope LabelingMice, Inbred BALB CMultimodal ImagingPositron-Emission TomographyTissue Distribution1,4,7-triazacyclononane-N,N',N''-triacetic acidCarbocyaninesCopper-64Copper RadioisotopesFluorescent DyesGallium-68Gallium RadioisotopesHeterocyclic Compounds, 1-Ringindotricarbocyaninebiodistributionexosomeoptical imagingPET imaging

Identifiers

PMID33105908
PMCPMC7660226
OpenAlexW3093870190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.